Explore › Condition › Diabetic Nephropathy
Condition

Diabetic Nephropathy

Also known as: Diabetes + nephropathy Diabetes + nephropathy (& [Kimmelstiel-Wilson syndrome]) Diabetes + nephropathy (& [Kimmelstiel-Wilson syndrome]) (disorder) Diabetes mellitis with nephropathy NOS Diabetes mellitis with nephropathy NOS (disorder) Diabetes mellitus with renal manifestation Diabetes mellitus with renal manifestation (disorder) Diabetes mellitus: [with renal manifestation] or [nephropathy] Diabetes mellitus: [with renal manifestation] or [nephropathy] (disorder) Diabetes with renal manifestations Diabetes with renal manifestations (disorder) Diabetic Kidney Disease +18 more
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Fenofibrate1
outcomes
Status of progression of development in middle adulthood1
populations
Type 2 Diabetes Patients1
studys
PMC45096011

Findings (27)

None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →
None
improvement

Fenofibrate added to simvastatin reduced progression of albuminuria in T2DM patients, with microalbuminuria reduced by 8.1% (p=0.01) and macroalbuminuria reduced by 14.6% (p=0.03) compared with simvas

Effect: improvement; Microalbuminuria -8.1%, macroalbuminuria -14.6%

Size: Microalbuminuria -8.1%, macroalbuminuria -14.6%
PMC4509601
Finding details → · Paper → · Graph →

Papers (1)